Neeti S. Kulkarni, David Hutton, Corwin Rhyan, Jeffrey S. McCullough, Michaela Greenlee, Ankur Pandya. The Conventional Cost‐Effectiveness and Distributional Cost‐Effectiveness of Semaglutide for Obesity Treatment. // Obesity. – 2026. – DOI: 10.1002/oby.70311. – URL: https://onlinelibrary.wiley.com/doi/10.1002/oby.70311?af=R
Neeti S. Kulkarni, David Hutton, Corwin Rhyan, Jeffrey S. McCullough, Michaela Greenlee, & Ankur Pandya (2026). The Conventional Cost‐Effectiveness and Distributional Cost‐Effectiveness of Semaglutide for Obesity Treatment. Obesity. https://doi.org/10.1002/oby.70311
Neeti S. Kulkarni, et al. “The Conventional Cost‐Effectiveness and Distributional Cost‐Effectiveness of Semaglutide for Obesity Treatment.” Obesity, 2026. doi:10.1002/oby.70311.
@article{Kulkarni2026,
title = {The Conventional Cost‐Effectiveness and Distributional Cost‐Effectiveness of Semaglutide for Obesity Treatment},
author = {Kulkarni, Neeti S. and Hutton, David and Rhyan, Corwin and McCullough, Jeffrey S. and Greenlee, Michaela and Pandya, Ankur},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70311},
url = {https://onlinelibrary.wiley.com/doi/10.1002/oby.70311?af=R}
}